These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 748005)

  • 1. Selective blockade of estrogen-induced uterine responses by the antiestrogen nafoxidine.
    Gardner RM; Kirkland JL; Stancel GM
    Endocrinology; 1978 Nov; 103(5):1583-9. PubMed ID: 748005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative study of antiestrogen action: temporal patterns of antagonism of estrogen stimulated uterine growth and effects on estrogen receptor levels.
    Ferguson ER; Katzenellenbogen BS
    Endocrinology; 1977 May; 100(5):1242-51. PubMed ID: 849721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of nafoxidine on the luteinizing hormone surge: temporal distribution of estrogen receptors and induction of cytoplasmic progestin receptors in the hypothalamus-preoptic area, pituitary, and uterus of the immature rat.
    Attardi B; Palumbo LA
    Endocrinology; 1981 Nov; 109(5):1365-74. PubMed ID: 7297482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiestrogen action in the uterus: biological ineffectiveness of nuclear bound estradiol after antiestrogen.
    Katzenellenbogen BS; Ferguson ER
    Endocrinology; 1975 Jul; 97(1):1-12. PubMed ID: 166821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of nafoxidine (U-11,100A) on the induction of uterine peroxidase.
    McNabb T; Jellinck PH
    Steroids; 1976 May; 27(5):681-9. PubMed ID: 181872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulatory and inhibitory effects of estrogen and antiestrogen on uterine cell division.
    Mukku VR; Kirkland JL; Hardy M; Stancel GM
    Endocrinology; 1981 Oct; 109(4):1005-10. PubMed ID: 7285857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential blockade of estrogen-induced uterine responses by the antiestrogen nafoxidine.
    Galand P; Mairesse N; Roorijck J; Flandroy L
    J Steroid Biochem; 1983 Sep; 19(3):1259-63. PubMed ID: 6194375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fundamental differences in the action of estrogens and antiestrogens on the uterus: comparison between compounds with similar duration of action.
    Katzenellenbogen BS; Ferguson ER; Lan NC
    Endocrinology; 1977 May; 100(5):1252-9. PubMed ID: 849722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different nuclear binding sites for antiestrogen and estrogen receptor complexes.
    Ruh TS; Baudendistel LJ
    Endocrinology; 1977 Feb; 100(2):420-6. PubMed ID: 832632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear bodies as structural indicators of estrogenic stimulation in uterine luminal epithelial cells.
    Padykula HA; Fitzgerald M; Clark JH; Hardin JW
    Anat Rec; 1981 Dec; 201(4):679-96. PubMed ID: 7340572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of estrogen receptor binding and transcriptional activity in the stimulation of hyperestrogenism and nuclear bodies.
    Clark JH; Hardin JW; Padykula HA; Cardasis CA
    Proc Natl Acad Sci U S A; 1978 Jun; 75(6):2781-4. PubMed ID: 275847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response of the mouse uterus to nafoxidine stimulation: agonism and antagonism.
    Quarmby VE; Fox-Davies C; Newbold RR; Korach KS
    Biol Reprod; 1988 May; 38(4):945-54. PubMed ID: 3401548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of the anti-oestrogen, nafoxidine hydrochloride, with the soluble nuclear oestradiol-binding protein in chick liver.
    Lazier CB; Alford WS
    Biochem J; 1977 Jun; 164(3):659-67. PubMed ID: 883957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA polymerase activity and uterine growth: Differential stimulation by estradiol, estriol, and nafoxidine.
    Hardin JW; Clark JH; Glasser SR; Peck EJ
    Biochemistry; 1976 Apr; 15(7):1370-4. PubMed ID: 944048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of low dose continuous exposure to estradiol on the estrogen receptor (type I) and nuclear type II sites.
    Markaverich BM; Roberts RR; Alejandro M; Clark JH
    Endocrinology; 1984 Mar; 114(3):814-20. PubMed ID: 6697964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time-related effects of a triphenylethylene antiestrogen on estrogen-induced changes in uterine weight, estrogen receptors, and endometrial sensitivity in rats.
    Trivedi RN; Chauhan SC; Dwivedi A; Kamboj VP; Singh MM
    Contraception; 1995 Jun; 51(6):367-79. PubMed ID: 7554978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison between the action of estradiol and that of the antiestrogen U 11-100 A on the induction in the rat uterus of a specific protein (the induced protein).
    Mairesse N; Galand P
    Endocrinology; 1979 Nov; 105(5):1248-53. PubMed ID: 488011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dephosphorylation of oestradiol nuclear receptor in vitro. A hypothesis on the mechanism of action of non-steroidal anti-oestrogens.
    Auricchio F; Migliaccio A; Castoria G
    Biochem J; 1981 Sep; 198(3):699-702. PubMed ID: 6275856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific binding and biological response of antiestrogens in the fetal uterus of the guinea pig.
    Gulino A; Pasqualini JR
    Cancer Res; 1980 Oct; 40(10):3821-6. PubMed ID: 7438065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear mechanisms of estrogen action. Effects of estradiol and anti-estrogens on estrogen receptors and nuclear receptor processing.
    Horwitz KB; McGuire WL
    J Biol Chem; 1978 Nov; 253(22):8185-91. PubMed ID: 711743
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.